Staff Reporter
,
Singapore
Photo from Novartis Singapore via Linkedin
The partnership focuses on radioligand therapy, cell therapy, and early-phase trials.
Singapore General Hospital (SGH) and Novartis Singapore have signed a memorandum of understanding (MoU) to advance clinical trials and research.
The partnership focuses on areas, such as radioligand therapy, cell therapy, and early-phase trials.
The MoU extends an existing partnership with SGH, which has facilitated up to 67 clinical trials, nearly half within the oncology field.
Join
Healthcare Asia Magazine
community
Since you're here...
...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!